Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

NCT04953312 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Abandonment of the study project

Conditions

Severe/Moderate Coronavirus
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes
Old Age

Interventions

BIOLOGICAL: Blood samples

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]